List of Tables:

TABLE 1 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 2 GLOBAL Cystic Fibrosis medication MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 3 GLOBAL CYSTIC FIBROSIS devices MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 4 GLOBAL CYSTIC FIBROSIS Other treatments MARKET, BY REGION, 2013-2027 ($MILLION)
TABLE 5 GLOBAL CYSTIC FIBROSIS MARKET, BY region, 2013-2022 ($Million)
TABLE 6 North America CYSTIC FIBROSIS MARKET, BY Country, 2013-2022 ($Million)
TABLE 7 North America CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 8 U.S. CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 9 Canada CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 10 Europe CYSTIC FIBROSIS MARKET, BY Country, 2013-2022 ($Million)
TABLE 11 europe CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 12 Germany CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 13 France CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 14 UK CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 15 Italy CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 16 Spain CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 17 Rest of western europe CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 18 Eastern europe CYSTIC FIBROSIS MARKET, BY treatment method, 2013-2022 ($Million)
TABLE 19 Asia-Pacific CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($Million)
TABLE 20 Asia-Pacific CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 21 Australia CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 22 Japan CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 23 China CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 24 India CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 25 Republic of Korea CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 26 Rest of Asia-Pacific CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 27 Middle East & Africa CYSTIC FIBROSIS MARKET, BY Region, 2013-2022 ($Million)
TABLE 28 Middle East & Africa CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 29 Middle East CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 30 Africa CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($Million)
TABLE 31 CHIESI Farmaceutici S.p.A.: Key Developments
TABLE 32 Vertex Pharmaceuticals Incorporated: Key Developments

LIST OF FIGURE

List of Figures:

FIGURE 1 Research Process of MRFR
FIGURE 2 PORTER'S 5 FORCES ANALYSIS OF GLOBAL CYSTIC FIBROSIS MARKET
FIGURE 3 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($Million)
FIGURE 4 GLOBAL CYSTIC FIBROSIS MARKET, BY Region, 2015 (%)
FIGURE 5 North America CYSTIC FIBROSIS MARKET, BY Country, 2015 (%)
FIGURE 6 North America CYSTIC FIBROSIS MARKET, BY treatment method, 2015 & 2022 ($Million)
FIGURE 7 Europe CYSTIC FIBROSIS MARKET, BY Country, 2015 (%)
FIGURE 8 europe CYSTIC FIBROSIS MARKET, BY treatment method, 2015 & 2022 ($Million)
FIGURE 9 Asia-Pacific CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%)
FIGURE 10 Asia-Pacific CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 % 2022 ($Million)
FIGURE 11 Middle East & Africa CYSTIC FIBROSIS MARKET, BY Region, 2015 (%)
FIGURE 12 Middle East & Africa CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($Million)
FIGURE 13 Cystic Finrosis Market Share, 2016 (%)
FIGURE 14 AbbVie: Recent Financial
FIGURE 15 AbbVie: Business Revenue, 2015 (%)
FIGURE 16 AbbVie: Geographic Revenue, 2015 (%)
FIGURE 17 ALLERGAN: RECENT FINANCIAL
FIGURE 18 Allergan: Business Revenue, 2015 (%)
FIGURE 19 Allergan: Geographic Revenue, 2015 (%)
FIGURE 20 CHIESI Farmaceutici S.p.A.: Recent Financials
FIGURE 21 F. Hoffmann-La Roche AG.: Recent Financials
FIGURE 22 F. Hoffmann-La Roche AG.: Business Revenue
FIGURE 23 GILEAD SCIENCES: RECENT FINANCIAL
FIGURE 24 Novartis AG: RECENT FINANCIALs
FIGURE 25 Novartis AG: Business Revenue, 2015 (%)
FIGURE 26 Novartis AG: Geographic Revenue, 2015 (%)
FIGURE 27 Pharmaxis Ltd: Recent Financials
FIGURE 28 PTC Therapeutics: Recent Financials
FIGURE 29 PTC Therapeutics: Geographical Revenue (%)
FIGURE 30 PTC Therapeutics: R&D Expenses, 2015 (%)
FIGURE 31 Vertex Pharmaceuticals Incorporated: Recent Financials
FIGURE 32 Vertex Pharmaceuticals Incorporated: Business Revenue
FIGURE 33 Vertex Pharmaceuticals Incorporated: Geographical Revenue